None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: more than 65 years 2. Subjects will be apparently healthy with 3. Subjects willing to sign an informed consent and adhere to all protocol requirements
Exclusion criteria
Exclusion criteria: 1. Treatment with anti-inflammatory/analgesic/antioxidant drugs in the previous month 2. Abnormal liver or renal function tests, laboratory findings suggestive of an active inflammatory or infectious process and presence of any known disease. 3. Pregnancy or breast feeding 4. Current alcoholism or drug abuse 5. Allergies to one of the component substances in the trial 6. Medication (active medication) 7. Participation in another clinical trial less than 3 months previously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the safety of herbal preparation in the management of sarcopeniaTimepoint: Day1 Day90 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the efficacy of herbal preparation in the management of sarcopeniaTimepoint: Day1 Day90 | — |
Countries
India
Contacts
BioAgile Therapeutics Pvt. Ltd